Skip to main content
OpenTrials
Completed

NCT Number: NCT00153504

Housing and Health Study

The goal of the project is to examine the impact of providing housing for people living with HIV who are homeless or at imminent risk of homelessness on their HIV disease progression, risks of transmitting HIV, and medical care access and utilization.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV AIDS Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections HIV Seropositivity Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Evidence is accumulating that homelessness and housing may be important factors that influence human immunodeficiency virus (HIV) sex and drug risk behaviors. Despite this apparent connection, few studies have investigated whether homelessness or unstable housing, compared with stable and adequate housing, is linked with HIV risk behaviors, and whether change in housing status is associated with change in risk behaviors.

The Housing and Health Study is a multi-site, multi-agency research collaboration. This project is a unique collaboration between federal agencies (the Department of Housing and Urban Development and the Centers for Disease Control and Prevention), local government agencies, universities, and private not-for-profit organizations.

The goal of the project is to examine the impact of providing housing for people living with HIV who are homeless or at imminent risk of homelessness on their disease progression, their risks of transmitting HIV, and medical care access and utilization. A total of 630 people living with HIV from three study sites complete the baseline study sessions. Half the participants (n=315) are randomly assigned to each of the two study groups. Treatment group participants receive Housing and Health Study housing rental assistance, and comparison group participants receive assistance finding housing according to local standard practice.

At baseline, 6, 12, and 18 months after baseline, participants complete study questionnaires and provide blood specimens to test for CD4 and viral load. In addition, the cost effectiveness of the study will be investigated by examining the HIV-related costs averted by providing housing to persons at high risk for transmitting HIV.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV seropositive
  • At least 18 years of age
  • English or Spanish speaking
  • Able to provide informed consent
  • Able to participate in data collection protocol
  • Categorized as low income (less than 80% of the Area Median Income)
  • Homeless or at imminent risk of homelessness
  • Able to provide information about identity

Exclusion criteria

-

Treatment and study plan

Housing and Health Study housing rental assistance

Behavioral

Standard local practice housing assistance

Behavioral

Primary outcomes

  1. HIV risk behaviors at 6, 12, and 18 months

  2. Biological measures of HIV-related health status

  3. Access to HIV/AIDS medical care

  4. Adherence to HIV/AIDS medical care, including compliance with HIV medication therapies

Secondary outcomes

  1. Cost and cost effectiveness of the intervention

  2. Proximal outcomes (e.g., increased condom use self-efficacy, social norms) associated with a reduction in HIV risk behaviors

  3. Social contact, employment outcomes, quality of life, mental health

Sponsors and collaborators

Lead sponsor

Centers for Disease Control and Prevention

Fed

Collaborators

  • Columbia University
  • Johns Hopkins University
  • RTI International
  • US Department of Housing and Urban Development
  • University of Pittsburgh

Registry information

Acronym: H&H

Important dates

Study start
2004
Study completion
2007
First posted
Sep 12, 2005
Registry last updated
Apr 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.